Cyclosporine 0.1% (Ikervis) as a corticoid-sparing agent in Lyell syndrome with KeraKlear keratoprosthesis.

Cyclosporine 0.1% was used in a patient with Lyell syndrome, which had undergone a KeraKlear keratoprosthesis implant due to the severe ocular involvement to avoid overuse of corticoid agents. To the best of our knowledge, this is the first reported case of cyclosporine 0.